Article10.5754/hge12692
Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.
Umut Kefeli,Suleyman Buyuberber,Murat Akyol,Ramazan Yıldız,Kaplan Ma,Aydın Çiltaş+13 more-2013-06-01-PubMed
4
TL;DRAbstract
Sunitinib is an effective treatment in Turkish patients with GISTs, with a clinical benefit of 73.7% and shows an acceptable tolerability.
Chat with Paper
AI Agents for this Paper
Sunitinib is an effective treatment in Turkish patients with GISTs, with a clinical benefit of 73.7% and shows an acceptable tolerability.
Keywords
SunitinibMedicineTolerabilityInternal medicineAdverse effectImatinibRetrospective cohort studyTyrosine-kinase inhibitor
Chat
Click to start Chat